Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy

Journal of Neuroimmunology

Volumn 179, Issue 1-2, 2006, Pages 180-185

  Monteiro de Almeida, Sergio ^a   Letendre, Scott ^b   Zimmerman, Joshua ^a   Kolakowski, Stephanie ^a   Lazzaretto, Deborah ^b   McCutchan, J Allen ^b   Ellis, Ronald ^b  

^a UCSD ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central nervous system; Cerebrospinal fluid; Chemokines; CSF cells; HIV; MCP 1

Indexed keywords

ANTIRETROVIRUS AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTOSIS; MALE; PLASMA; PLEOCYTOSIS; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; CEREBROSPINAL FLUID; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; DRUG ADMINISTRATION SCHEDULE; HIV INFECTIONS; HUMANS; LEUKOCYTOSIS; MALE; MIDDLE AGED;

EID: 33748983209     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.06.018     Document Type: Article

References (38)

1. Abraham S., Sawaya B.E., et al. Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology 309 2 (2003) 196-202
2. Albini A., Ferrini S., et al. HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. U. S. A. 95 22 (1998) 13153-13158
3. Andersson M., Bergstrom T., et al. Cerebrospinal fluid changes in HIV-1 infection. Ann. N. Y. Acad. Sci. 540 (1988) 624-627
4. Appleman M.E., Marshall D.W., et al. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J. Infect. Dis. 158 1 (1988) 193-199
5. Babcock A.A., Kuziel W.A., et al. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 23 21 (2003) 7922-7930
6. Bartosik-Psujek H., and Stelmasiak Z. The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease. Eur. J. Neurol. 12 1 (2005) 49-54
7. Biber K., Zuurman M.W., et al. Chemokines in the brain: neuroimmunology and beyond. Curr. Opin. Pharmacol. 2 1 (2002) 63-68
8. Biernacki K., Prat A., et al. Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J. Neuropathol. Exp. Neurol. 60 12 (2001) 1127-1136
9. Conant K., Garzino-Demo A., et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. U. S. A. 95 6 (1998) 3117-3121
10. El-Hage N., Wu G., et al. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53 2 (2006) 132-146
11. Ellis R.J., Hsia K., et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann. Neurol. 42 5 (1997) 679-688
12. Eugenin E.A., Osiecki K., et al. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 26 4 (2006) 1098-1106
13. Hagberg L., Forsman A., et al. Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients. Infection 16 1 (1988) 13-18
14. Hall C.D., Snyder C.R., et al. Cerebrospinal fluid analysis in human immunodeficiency virus infection. Ann. Clin. Lab. Sci. 22 3 (1992) 139-143
15. Hickey W.F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1 2 (1991) 97-105
16. Hicks A., Potula R., et al. Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages. Am. J. Pathol. 161 3 (2002) 813-822
17. Hollander H., McGuire D., et al. Diagnostic lumbar puncture in HIV-infected patients: analysis of 138 cases. Am. J. Med. 96 3 (1994) 223-228
18. Katz R.L., Alappattu C., et al. Cerebrospinal fluid manifestations of the neurologic complications of human immunodeficiency virus infection. Acta Cytol. 33 2 (1989) 233-244
19. Kaul M., and Lipton S.A. Signaling pathways to neuronal damage and apoptosis in human immunodeficiency virus type 1-associated dementia: chemokine receptors, excitotoxicity, and beyond. J. Neurovirology 10 Suppl 1 (2004) 97-101
20. Kaul M., Zheng J., et al. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12 Suppl 1 (2005) 878-892
21. Kelder W., McArthur J.C., et al. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann. Neurol. 44 5 (1998) 831-835
22. Lee Y.B., Nagai A., et al. Cytokines, chemokines, and cytokine receptors in human microglia. J. Neurosci. Res. 69 1 (2002) 94-103
23. Livramento J.A., Machado L.R., et al. Cerebrospinal fluid abnormalities in 170 cases of AIDS. Arq. Neuro-Psiquiatr. 47 3 (1989) 326-331
24. Marshall D.W., Brey R.L., et al. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch. Neurol. 45 9 (1988) 954-958
25. Masopust D., Vezys V., et al. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291 5512 (2001) 2413-2417
26. Monteiro de Almeida S., Letendre S., et al. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. J. Neuroimmunol. 169 1-2 (2005) 144-152
27. Murphy P.M. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54 2 (2002) 227-229
28. Narikawa K., Misu T., et al. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J. Neuroimmunol. 149 1-2 (2004) 182-186
29. Neuenburg J.K., Furlan S., et al. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. Aids 19 13 (2005) 1351-1359
30. Pashenkov M., Teleshova N., et al. Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J. Neuroimmunol. 122 1-2 (2002) 106-116
31. Press R., Pashenkov M., et al. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J. Clin. Immunol. 23 4 (2003) 259-267
32. Price R.W. The two faces of HIV infection of cerebrospinal fluid. Trends Microbiol. 8 9 (2000) 387-391
33. Price R.W., and Deeks S.G. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: clinical and pathogenetic implications for the central nervous system. J. Neurovirol. 10 Suppl 1 (2004) 44-51
34. Price R.W., Paxinos E.E., et al. Cerebrospinal fluid response to structured treatment interruption after virological failure. Aids 15 10 (2001) 1251-1259
35. Weiss J.M., and Berman J.W. Astrocyte expression of monocyte chemoattractant protein-1 is differentially regulated by transforming growth factor beta. J. Neuroimmunol. 91 1-2 (1998) 190-197
36. Weiss J.M., Nath A., et al. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J. Immunol. 163 5 (1999) 2953-2959
37. Wilms H., Sievers J., et al. Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J. Neuroimmunol. 144 1-2 (2003) 139-142
38. Zink M.C., Coleman G.D., et al. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J. Infect. Dis. 184 8 (2001) 1015-1021